Selective Postoperative Hemoglobin Testing After Cesarean Delivery: A Predictive Model for Severe Postpartum Anemia.

Area of Science:

• Obstetrics and Gynecology
• Anesthesiology
• Health Services Research

Background:

• Cesarean delivery is a common surgery with higher postpartum blood loss than vaginal delivery.
• Routine postoperative hemoglobin testing after cesarean delivery is common but may be excessive.
• Identifying high-risk patients can optimize laboratory testing and resource allocation.

Purpose of the Study:

• To develop and validate a predictive model for severe postpartum anemia following cesarean delivery.
• To identify key clinical factors for predicting severe postpartum anemia.
• To evaluate the potential of a risk-based approach for postoperative hemoglobin testing.

Main Methods:

• Retrospective cohort study of 2,061 patients undergoing cesarean delivery.
• Extraction of demographic, obstetric, and clinical variables from electronic health records.
• Elastic net logistic regression with cross-validation to identify predictors of severe postpartum anemia (hemoglobin <7 g/dL).

Main Results:

• Severe postpartum anemia occurred in 3.8% of patients; 5.6% received blood transfusion.
• The final predictive model included preoperative hemoglobin level and number of uterotonic agents administered.
• The model showed strong discrimination (AUC: 0.89) and could reduce testing by 65% while maintaining 90% sensitivity.

Conclusions:

• Preoperative hemoglobin and uterotonic use effectively identify patients at high risk for severe postpartum anemia.
• A risk-based strategy for postoperative hemoglobin testing can improve resource utilization.
• Selective testing may align with guidelines, reduce unnecessary labs, and maintain patient safety.